Literature DB >> 4103868

[The significance of the beta 1C-1A content in serum of patients with the so-called "lupoid" hepatitis].

C Mueller-Eckhardt, G Kretzschmar, H A Kühn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4103868     DOI: 10.1007/BF01485101

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


× No keyword cloud information.
  9 in total

1.  Anti-nuclear factors and serum complement in systemic lupus erythematosus.

Authors:  J H MORSE; H J MULLER-EBERHARD; H G KUNKEL
Journal:  Bull N Y Acad Med       Date:  1962-10

2.  Altered complement component C3A (beta-1C--beta-1A) in patients with glomerulonephritis.

Authors:  J F Soothill
Journal:  Clin Exp Immunol       Date:  1967-01       Impact factor: 4.330

3.  Normal values for 23 different human plasma proteins determined by single radial immunodiffusion.

Authors:  K Störiko
Journal:  Blut       Date:  1968-01

4.  [Studies on the importance of the fluorescence-antiglobulin test and the antiglobulin-consumption test for the demonstration of antinuclear serum factors].

Authors:  C Mueller-Eckhardt; K Schmidt; W Becker
Journal:  Blut       Date:  1968-07

5.  [Autoimmunity in hepatology: serologic exploration by complement deviation, passive hemagglutination and precipitation].

Authors:  A Eyquem; L Gurow
Journal:  Acta Gastroenterol Belg       Date:  1968-06       Impact factor: 1.316

6.  Classification and treatment of chronic active liver disease.

Authors:  M G Geall; L J Schoenfield; W H Summerskill
Journal:  Gastroenterology       Date:  1968-12       Impact factor: 22.682

7.  Clinical studies of hemolytic complement and the 11S component.

Authors:  L B Hanauer; C L Christian
Journal:  Am J Med       Date:  1967-06       Impact factor: 4.965

8.  [Quantitative serum immunoglobulin determinations in inflammatory liver diseases. II. Chronic inflammatory liver diseases].

Authors:  E Gleichmann; H Deicher
Journal:  Klin Wochenschr       Date:  1968-08-01

9.  Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients.

Authors:  C A Alper; F S Rosen
Journal:  J Clin Invest       Date:  1967-12       Impact factor: 14.808

  9 in total
  1 in total

1.  The serum concentration of the third component of complement beta-1C-beta-1A in liver disease.

Authors:  R A Fox; F J Dudley; S Sherlock
Journal:  Gut       Date:  1971-07       Impact factor: 23.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.